InSphero AG, the leading supplier of advanced, yet easy-to-use 3D cell culture-based solutions for drug discovery and development, today announced the launch of 3D InSight™ Monkey Liver Microtissues, ...
Monthly contract screening service simplifies long-term, repeat-dose testing of drugs in 3D human liver microtissues for global pharmaceutical market. InSphero AG, the leading supplier of easy-to-use ...
SCHLIEREN, Switzerland and SAN FRANCISCO, Oct. 3, 2019 /PRNewswire/ -- Akero Therapeutics and InSphero AG today announced that Akero has selected InSphero's 3D InSight™ Human Liver Disease Platform to ...
SCHLIEREN, Switzerland--(BUSINESS WIRE)--InSphero AG, the pioneer of 3D cell-based assay technology, today announced that the company is making their proprietary, patented 96- and 384-microwell plates ...
ZüRICH, SWITZERLAND, November 25, 2024 /EINPresswire.com/ -- InSphero, the global leader in 3D cell culture technology, and scientists from the U.S. Food and Drug ...
ZURICH, Oct. 15, 2024 /PRNewswire/ -- InSphero, the global leader in 3D cell culture technology, and scientists from the U.S. Food and Drug Administration's (FDA) National Center for Toxicological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results